More articles from Endocrinology: Management of Thyroid Cancer in 2010

You have access
I-131 therapy in differentiated thyroid cancer (DTC) using recombinant human thyroid stimulating hormone (rhTSH): Biokinetic data and proposed dosing scheme
Jon Umlauf, Antoine Leblond, Shelley Hartnett and David Mankoff

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 146;
You have access
Relationship among Tc-99m uptake, FDG uptake, and clinical behavior in bone metastases from differentiated thyroid carcinoma
Kunihiro Nakada, Ichiro Sakuma, Masayuki Sakurai and Hiromasa Takahasi

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 144;
You have access
When to evaluate the final success rate of thyroid remnant ablation following low dose I-131 administration?
Medvedec Mario

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 147;
You have access
Impact of TNM status on rhTSH-aided I-131 thyroid remnant ablation (rhTSH-A) success in patients (pats) with differentiated thyroid cancer (DTC): Preliminary data from an international, multicenter retrospective study
Teresa Ferreira, Juan Antonio Vallejo, Mikhailo Brezhnev, Lutz Freudenberg, Sergey Cherenko, Daria Handkiewicz-Junak, Leonidas Duntas, Frederik Verburg, Robert Marlowe and Thorsten Petrich

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 149;
You have access
Radioiodine thyroid remnant ablation (RRA) in patients with differentiated thyroid cancer (DTC): Impact of recombinant human thyroid-stimulating hormone (rhTSH) on treatment room length-of-stay and utilization
Juan Antonio Vallejo, Luisa Mena, María Angeles Galvez, Robert Marlowe and José Latre

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 148;
You have access
Changes in biochemical parameters in thyroid cancer patients preparing for radioiodine ablation after total thyroidectomy: Thyroxine withdrawal vs. rhTSH injection
Kwang Uk Bae, Sung Hoon Kim, Joo Hyun Oo, Young Ha Park, Hyung Sun Sohn and Soo Kyo Chung

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 145;
You have access
Response to radioiodine therapy in thyroglobulin-elevated negative iodine scintigraphy (TENIS) syndrome: Stratification by thyroglobulin (Tg) level
Hollie West, Gary Conrad and Partha Sinha

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 150;

Main menu

User menu

Search

More articles from Endocrinology: Management of Thyroid Cancer in 2010